𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Viral load in hepatitis B e antigen–negative carriers with normal aminotransferase level

✍ Scribed by Yun-Fan Liaw

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
70 KB
Volume
46
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B viral factors in HBeAg-Negat
Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levels
✍ Chih-Lin Lin; Li-Ying Liao; Chun-Jen Liu; Ming-Whei Yu; Pei-Jer Chen; Ming-Yang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

Chronic hepatitis B patients with high-normal serum ALT (levels of 0.5-1؋ upper limit of normal) are still at risk of liver disease progression. We thus investigated the correlation between serum ALT level and hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum ALT le

Long-term outcome of hepatitis B e antig
Long-term outcome of hepatitis B e antigen–negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time
✍ Dar-In Tai; Shi-Ming Lin; I-Shyan Sheen; Chia-Ming Chu; Deng-Yn Lin; Yun-Fan Lia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 1 views

The baseline alanine aminotransferase (ALT) level was reported to have prognostic value in chronic hepatitis B virus (HBV) infection, during which ALT may change over time. Instead of baseline ALT, this study aimed to study the prognostic value of the height of ALT during the course of chronic HBV i

Liver biopsy in hepatitis C virus carrie
Liver biopsy in hepatitis C virus carriers with normal alanine aminotransferase levels
✍ Laudio Puoti; Lia Bellis; Riccardo Guarisco 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

surface antigen (HBsAg) but also in patients with "resolved" HBV infection. 5,6 In a retrospective analysis of lymphoma patients who were HBsAg-negative and anti-HBV core antigen (anti-HBc) positive, 5 of the 21 patients who received chemotherapy plus rituximab, an anti-CD20 antibody, developed hepa

Virological response to interferon treat
Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis
✍ A Rossini; A Ravaggi; L Biasi; E Agostinelli; L Bercich; G B Gazzola; F Callea; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 2 views

Hepatitis C virus (HCV) carriers with normal aminotransferase levels often show histological chronic hepatitis. This study was undertaken to determine the effect of interferon (IFN) in such patients. Nineteen HCV carriers with normal aminotransferase activities and chronic hepatitis were randomized